Immutep Limited - a global leader in development of immunotherapy for cancer & autoimmune diseases
Immutep (ASX: IMM) and (FRA: YP1B) are the global leaders in understanding and development of therapeutics that modulate Lymphocyte...
top of page
Search
bottom of page